Global Co-immunoprecipitation (Co-IP) Service Market Growth (Status and Outlook) 2025-2031
Description
The global Co-immunoprecipitation (Co-IP) Service market size is predicted to grow from US$ 491 million in 2025 to US$ 669 million in 2031; it is expected to grow at a CAGR of 5.3% from 2025 to 2031.
Co-immunoprecipitation (Co-IP) service is a method for studying protein interactions based on the interaction between antibodies and antigens. The principle is to use endogenous target proteins in cells as bait, co incubate target protein antibodies with total cell proteins, and promote the formation of immune complexes. Subsequently, protein A/G that can bind to the target protein antibody is added to form a "binding protein target protein target protein antibody" complex. After purification, the immune complex is separated by gel electrophoresis, combined with Western blot or mass spectrometry technology, so as to purify the target protein and qualitatively detect antigen or antibody.
United States market for Co-immunoprecipitation (Co-IP) Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Co-immunoprecipitation (Co-IP) Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Co-immunoprecipitation (Co-IP) Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Co-immunoprecipitation (Co-IP) Service players cover Creative Proteomics, Lifeasible, ThermoFisher Scientific, Profacgen, Creative BioMart, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Co-immunoprecipitation (Co-IP) Service Industry Forecast” looks at past sales and reviews total world Co-immunoprecipitation (Co-IP) Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Co-immunoprecipitation (Co-IP) Service sales for 2025 through 2031. With Co-immunoprecipitation (Co-IP) Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Co-immunoprecipitation (Co-IP) Service industry.
This Insight Report provides a comprehensive analysis of the global Co-immunoprecipitation (Co-IP) Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Co-immunoprecipitation (Co-IP) Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Co-immunoprecipitation (Co-IP) Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Co-immunoprecipitation (Co-IP) Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Co-immunoprecipitation (Co-IP) Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Co-immunoprecipitation (Co-IP) Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
Tag Protein Immunoprecipitation
Non Tagged Protein Immunoprecipitation
Chromatin Immunoprecipitation
Segmentation by Application:
Drug Development
Biomedical Research
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Creative Proteomics
Lifeasible
ThermoFisher Scientific
Profacgen
Creative BioMart
Biologics International Corp
Creative Diagnostics
CD BioSciences
Beijing Abace Biology
Nanjing Detai Bioengineering
Guangzhou Fitgene Biotechnology
Nanjing Zoonbio Biotechnology
Shanghai Beyotime Biotechnology
Beijing Bio-Tech Pack Scientific
Wuhan Genecreate
Wuhan Biorun BioSciences
Please note: The report will take approximately 2 business days to prepare and deliver.
Co-immunoprecipitation (Co-IP) service is a method for studying protein interactions based on the interaction between antibodies and antigens. The principle is to use endogenous target proteins in cells as bait, co incubate target protein antibodies with total cell proteins, and promote the formation of immune complexes. Subsequently, protein A/G that can bind to the target protein antibody is added to form a "binding protein target protein target protein antibody" complex. After purification, the immune complex is separated by gel electrophoresis, combined with Western blot or mass spectrometry technology, so as to purify the target protein and qualitatively detect antigen or antibody.
United States market for Co-immunoprecipitation (Co-IP) Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Co-immunoprecipitation (Co-IP) Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Co-immunoprecipitation (Co-IP) Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Co-immunoprecipitation (Co-IP) Service players cover Creative Proteomics, Lifeasible, ThermoFisher Scientific, Profacgen, Creative BioMart, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Co-immunoprecipitation (Co-IP) Service Industry Forecast” looks at past sales and reviews total world Co-immunoprecipitation (Co-IP) Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Co-immunoprecipitation (Co-IP) Service sales for 2025 through 2031. With Co-immunoprecipitation (Co-IP) Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Co-immunoprecipitation (Co-IP) Service industry.
This Insight Report provides a comprehensive analysis of the global Co-immunoprecipitation (Co-IP) Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Co-immunoprecipitation (Co-IP) Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Co-immunoprecipitation (Co-IP) Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Co-immunoprecipitation (Co-IP) Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Co-immunoprecipitation (Co-IP) Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Co-immunoprecipitation (Co-IP) Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
Tag Protein Immunoprecipitation
Non Tagged Protein Immunoprecipitation
Chromatin Immunoprecipitation
Segmentation by Application:
Drug Development
Biomedical Research
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Creative Proteomics
Lifeasible
ThermoFisher Scientific
Profacgen
Creative BioMart
Biologics International Corp
Creative Diagnostics
CD BioSciences
Beijing Abace Biology
Nanjing Detai Bioengineering
Guangzhou Fitgene Biotechnology
Nanjing Zoonbio Biotechnology
Shanghai Beyotime Biotechnology
Beijing Bio-Tech Pack Scientific
Wuhan Genecreate
Wuhan Biorun BioSciences
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
121 Pages
- 1 Scope of the Report
- 2 Executive Summary
- 3 Co-immunoprecipitation (Co-IP) Service Market Size by Player
- 4 Co-immunoprecipitation (Co-IP) Service by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Co-immunoprecipitation (Co-IP) Service Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
